tiprankstipranks
Trending News
More News >
Sinopharm Group Co (SHTDY)
OTHER OTC:SHTDY
US Market

Sinopharm Group Co (SHTDY) Income Statement

Compare
21 Followers

Sinopharm Group Co Income Statement

Last quarter (Q2 2025), Sinopharm Group Co's total revenue was ¥286.04B, a decrease of -4.95% from the same quarter last year. In Q2, Sinopharm Group Co's net income was ¥3.46B. See Sinopharm Group Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 584.51B¥ 596.57B¥ 552.15B¥ 521.05B¥ 456.41B
Gross Profit
¥ 44.26B¥ 48.51B¥ 47.43B¥ 44.05B¥ 40.32B
Operating Expenses
¥ 28.07B¥ 28.30B¥ 26.83B¥ 24.34B¥ 22.56B
Depreciation and Amortization
¥ 2.36B¥ 4.43B¥ 4.17B¥ 3.92B¥ 3.60B
EBITDA
¥ 20.17B¥ 26.90B¥ 26.25B¥ 24.68B¥ 22.62B
Operating Income
¥ 16.19B¥ 20.21B¥ 20.60B¥ 19.71B¥ 17.76B
Other Income/Expenses
¥ -2.19B¥ -697.06M¥ -2.04B¥ -2.71B¥ -2.16B
Pretax Income
¥ 14.00B¥ 19.51B¥ 18.56B¥ 17.00B¥ 15.60B
Net Income
¥ 7.05B¥ 9.05B¥ 8.53B¥ 7.76B¥ 7.19B
Per Share Metrics
Basic EPS
¥ 11.30¥ 14.50¥ 13.65¥ 12.45¥ 11.55
Diluted EPS
¥ 11.30¥ 14.50¥ 13.65¥ 12.45¥ 11.55
Weighted Average Shares Outstanding
624.11M 624.13M 624.13M 622.23M 622.23M
Weighted Average Shares Outstanding (Diluted)
624.11M 624.13M 624.13M 622.23M 622.26M
Currency in CNY

Sinopharm Group Co Earnings and Revenue History